Key facts
- This page summarizes Craig Eagle's Form 4 filing for Guardant Health, Inc. (GH).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 09 Nov 2022, 16:32.
Craig Eagle - 07 Nov 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)
- Reporting relationship
- CHIEF MEDICAL OFFICER
- Issuer ticker
- GH
- Reported as of
- 07 Nov 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 09 Nov 2022, 16:32:12 UTC
- Prior SEC filing
- 08 Sep 2022
- Next SEC filing
- 16 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Saia, as attorney-in-fact for Craig Eagle
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Craig Eagle filed Form 4 for Guardant Health, Inc. (GH) on 09 Nov 2022.
Change
- Previous filing in this sequence was filed on 08 Sep 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GH
transaction
Derivative
STOCK OPTION (RIGHT TO BUY)
Award
- Transaction value
- $0
- Shares
- +54,852
- Change %
- Price
- $0.000000
- Shares after
- 54,852
- Date
- 07 Nov 2022
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount
- 54,852
- Exercise price
- $47.20
- Footnotes
- F1
GH
transaction
Derivative
RESTRICTED STOCK UNITS
Award
- Transaction value
- $0
- Shares
- +27,426
- Change %
- Price
- $0.000000
- Shares after
- 27,426
- Date
- 07 Nov 2022
- Ownership
- Direct
- Underlying class
- COMMON STOCK
- Underlying amount
- 27,426
- Exercise price
- $0.000000
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
This represents a stock option granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter.
Footnote F2
This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
Footnote F3
Not applicable to Restricted Stock Units.